SCHEMBL5306285

SCHEMBL5306285

Nc1ccc2c(c1)SCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
KDM4E B2RXH2 3/20 0.36
CA9 Q16790 2/20 0.36
GAA P10253 2/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CA2 P00918 2/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
VHL P40337 1/20 0.32
ELOC Q15369 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28596137 0.88 MAPT (0.34) MAPTMEN1KMT2AKDM4ECA9
SCHEMBL3924933 0.83 CASP1 (0.39) MAPTMEN1KMT2AKDM4ECA9
SCHEMBL17058097 0.77
SCHEMBL13515896 0.75 TAAR1 (0.40) MAPTKDM4EGAAALDH1A1LMNA
SCHEMBL13871893 0.74 CRBN (0.30)
SCHEMBL5430890 0.74 PBRM1 (0.39) CA2DRD3
SCHEMBL12068378 0.74 EPHX2 (0.39) MAPTMEN1KMT2AKDM4EGAA
SCHEMBL3348087 0.71 KDM1A (0.43) MAPTKDM4EGAAALDH1A1HSD17B10
SCHEMBL12296552 0.69 IDO1 (0.36) MAPTLMNA
SCHEMBL7241941 0.69 GRIN2B (0.33) MAPTLMNAHPGDHSD17B10HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018160944-A1 AZOLE COMPOUNDS AS UBIQUITIN-SPECIFIC PROTEASE USP7 INHIBITORS PROGENRA, INC. (US) 2018-09-07 WO disclosed
EP-3157919-A1 BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS Bayer Pharma Aktiengesellschaft (DE) 2017-04-26 EP disclosed
WO-2015193219-A1 BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-12-23 WO disclosed
WO-2007028445-A1 6-INDOLYL-4-YL-AMINO-5-HALOGENO-2-PYRIMIDINYL-AMINO DERIVATIVES GLAXO GROUP LIMITED (GB) 2007-03-15 WO disclosed
EP-1730133-A1 BENZOTHIOPHENE- AND THIOCHROMENE CONTAINING PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISORDERS GLAXO GROUP LIMITED (GB) 2006-12-13 EP disclosed
WO-2005058867-A1 BENZOTHIOPHENE-AND THIOCHROMENE CONTAINING PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISORDERS GLAXO GROUP LIMITED (GB) 2005-06-30 WO disclosed
EP-1377550-A1 PHENYL HETEROCYCLYL ETHER DERIVATIVES AS SEROTONIN RE-UPTAKE INHIBITORS Pfizer Limited (GB) 2004-01-07 EP disclosed
EP-1313701-A1 PHENOXYBENZYLAMINE DERIVATIVES AS SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS Pfizer Limited (GB) 2003-05-28 EP disclosed
WO-2002083643-A1 PHENYL HETEROCYCLYL ETHER DERIVATIVES AS SEROTONIN RE-UPTAKE INHIBITORS PFIZER LIMITED (GB) 2002-10-24 WO disclosed
WO-2002018333-A1 PHENOXYBENZYLAMINE DERIVATIVES AS SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS PFIZER LIMITED (GB) 2002-03-07 WO disclosed